From Legacy to Leadership
innovation worldwide.
S Kant Healthcare: A Legacy Forged in Quality, Driven by Global Ambition
Established in 1996 and strategically headquartered in Mumbai, India, S Kant Healthcare Ltd. embarked on a journey destined to transform it into a preferred partner of choice for the global pharmaceutical industry.
Our genesis was marked by the pivotal acquisition of a substantial manufacturing site in Vapi, India, from the esteemed M/s Solvay-Duphar. This acquisition provided an immediate foundation with capabilities spanning Finished Formulations, APIs, Metallic Stearates, and Herbal Extracts, offering a strong starting point for our vision.
The following timeline highlights our company’s growth milestones.
Mission
To be a trusted global supplier of affordable, quality generic medicines, ensuring their availability to patients and institutions worldwide.
Vision
To be recognized as the premier partner in generic pharmaceuticals, setting benchmarks for quality, compliance, and supply chain reliability.
Backward Integration: The Foundation of Reliability
With access to six API manufacturing sites across the SK Group— including in-house capabilities at S Kant itself— we gain a crucial strategic advantage. This integration ensures assured, consistent supply, robust end-to-end quality management, and greater commercial competitiveness.
The S Kant Difference: Capabilities that Deliver
S Kant Healthcare has development and manufacturing capabilities for non-beta-lactam finished formulations across the following dosage forms:
Oral Solids
Tablet
Capsule
Powder for Suspension
Oral Liquids
Syrup
Solution
Suspension
Semi Solid
Cream
Ointment
Gel
Oral Gel
Quality Accreditations and Global Compliance
Global Presence and Market Reach
Our products are currently available in 85 countries, with dedicated operational presence including offices in Burkina Faso, Nigeria and active marketing teams in East Africa. The foundation of our long-term African strategy is a manufacturing site nearing completion in Uganda. This landmark facility will not only enhance access across East Africa but also realize our goal to “Make in Africa for Africa—localizing the production of essential medicines to better support global health objectives.
What’s New at S Kant
S Kant recent foray has been in the Indian pharmaceutical market with focus on aesthetic dermatology ethically marketed in India through its division DermX-Expect Excellence. These dermatological products are co-created with leading dermatologists ensuring efficacious and quality solutions to the patient
